transmembrane protein (pIg receptor) of approximately 100 kDa basolaterally on secretory epithelial cells (Mostov and Blobel, 1982) . It mediates the external transport of dimers and higher polymers of IgA (pIgA) as well as pentameric IgM (pIgM) across secretory epithelia (reviewed by Brandtzaeg et al., 1994) . This function is unique for transmembrane SC, which is responsible for a daily translocation of approximately 40 mg secretory IgA (SIgA) kg-' body weight to the intestinal juice (Conley and Delacroix, 1987) . Immunohistochemical studies (Brandtzaeg, 1985) and Northern blot analyses (Krajbi et al., 1989) have demonstrated abundant expression of SC by glandular epithelia, particularly by the intestinal crypt cells.
SC protein expression is significantly reduced in dysplastic epithelium as seen in ulcerative colitis (Rognum et al., 1982a) . One immunodeficient case showing virtually undetectable SIgA in jejunal fluid (Nussinson et al., 1986) and two cases lacking SIgA in both saliva and jejunal fluid (Krakuer et al., 1975; Strober et al., 1976) have been reported. However, absence of SC production was not documented and compensatory secretion of pIgM was suggested as discussed elsewhere . In fact re-examination of one of the patients decribed by Strober et al. (1976) conluded that the SC deficiency had been transient rather than acquired (Plaut and Ridker, 1992) . It has been concluded that there is no convincing documentation that a primary SC deficiency may exist , which agrees with the notion that the pIg receptor has a crucial protective role at the mucosal surfaces. SC expression is often upregulated in diseased secretory tissue (Scott et al., 1981; Valnes et al., 1984; Thrane et al., 1992) , probably reflecting a modulating effect of various cytokines as shown in vitro (Sollid et al., 1987; Kvale et al., 1988; Phillips et al., 1990; Krajbi et al., 1993; Piskurich et al., 1993) .
Colorectal tumours were found to display reduced expression of SC protein being negatively related to the grade of dysplasia in adenomas (Isaacson, 1982; Rognum et al., 1982b) and to the histological grade as well as Dukes' stage in colorectal carcinomas (Rognum et al., 1980; Koretz et al., 1994) . These observations suggested that SC might be a marker for the malignant potential of colonic adenomas. Similar studies on SC mRNA expression were not possible until the cloning of human transmembrane SC cDNA had been achieved (KrajZi et al., 1989; . The aim of the present study was to investigate the mRNA-protein relationship for SC in colorectal adenomas and carcinomas.
Mateials and methods Patients groups
Northern blot analysis and inmunohistochemistry Thirty-three colorectal adenomas, all exceeding 1 cm in diameter, were collected during endoscopic examination of 31 patients (mean age 70 years, range 51-82 years) with gastrointestinal complaints. Clinicopathological information is shown in Table I . Faecal blood was detected in 12 of the patients (39%), three (10%) had first-degree relatives with sporadic colorectal carcinoma, four (13%) had first-degree relatives with breast cancer, two (6%) had first-degree relatives with genital cancer, and five (16%) had first-degree relatives with other cancers (each patient exhibited at least one of the associations listed above). As a group these patients were deemed to be at higher risk of developing sporadic colorectal cancer than other similarly aged adenoma patients (Hoff et al., 1986) . The tendency to adenoma formation (followed colonoscopically for 3 years) showed an increasing median number of tumours (from 3.1 to 5. (Figures 1 and 2a) (Figure 3) . Reduced SC mRNA levels were noted in 11 of the 12 adenomas that had an SC staining score of 0-1. but only in 4 of those 19 that had a score of 2-3 (Figure 4) SC mRVA in relation to immunofluorescence staining SC mRNA of normal size w-as detected in 17 of the tumours. Reduced SC mRNA lexels wxere noted in sexen of the ten tumours that had an SC staining score of 0. but onlv two of them totallv lacked the specific message (Table II) . Reduced mRNA levels tended to be less common (txx-o cases) among the eight tumours that had an SC staining score of 1 -3. although there was no statistically significant difference because of the small number of samples (P=0.07).
The four samples studied from a single carcinoma showed a slightly heterogeneous immunofluoresence staining pattern with intensity scores ranging from 0 to 1. but the mRNA levels appeared to be similar. Southern analysis of RFLP and allelic alterations at the D1S58 locus Piull revealed a two-allelic poly-morphism for DlS58. namely a 5.0 kb (allele Al) and a 4.5 kb (allele A2) fragment.
Twenty-two cases (22 32=69%) w-ere heterozvgous (informative) for polymorphism on locus DlS58. Heterozygous loss (Figure 6 ) xwas demonstrated in four of these tumours (18%). In one additional case (3/0o) loss of the D1S58 locus was observed on both chromosome lq arms (Table III) . 
Discussion
This studv is the first attempt to analx se the relativ-e SC mRNA expression in colorectal tumours. The increased risk of cancer in adenomas is related to the grade of dysplasia. the tumour size (Morson. 1974) . the tendency of bleeding (Doran and Hardcastle. 1982) . the tumour number (Matek et al.. 1985 In tw-o carcinomas absent SC protein expression was clearly explained by lack of specific message. which was verified by repeated RNA extractions from parallel tumour samples. Possible reasons for this lack of SC mRNA might be found at the transcnrptional level. such as deletions of the SC gene or its regulatory units or absence of protein factor(s) essential for its transcnption. Putative deletions would have to involve the SC-encoding gene (locus PIGR) on both chromosomes to cause absent message. PIGR is located in the lq31-q41 region (Davidson et al.. 1988 : Krajci et al., 1991 . which is involved in a large number of recombinantorial events (Brito-Babapulle and Atkin, 1981) . Using poly-morphic DNA markers. Vogelstein et al. (1989) demonstrated that allelic loss on chromosome lq occurs in approximately' 25% of colorectal carcinomas: the corresponding loss of both alleles would then occur at a frequency of about 6%. When we analysed genomic DNA extracted from colonic carcinomas for allelic alterations of locus Dl S58. which exhibits a centromeric location of PIGR (Krajci et al.. 1992) . heterozygous loss of this allele was revealed in 18% and loss of both alleles in 30 of the cases. The estimated frequency of simultaneous loss of both alleles [(4 22):'+ 1 32] would be more than 6% and might well account for at least one of the two SC mRNA-negative tumour carcinomas. Nevertheless, because the SC mRNA and RFLP analyses A-ere performed on different carcinoma materials. it cannot be excluded that the association between the frequency of SC mRNA loss and the frequency of diallelic loss of locus D1S58 is coincidental.
In conclusion, the positive relationship between mRNA and protein levels of SC observed in colorectal adenomas seemed to be the case also for carcinomas which, however. 
